Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Subjects:

Correlation test. by Tiantian Dong (6247917)

“…The findings indicate that consumption inequality has a significant negative impact on SWB. Specifically, for every unit increase in consumption inequality, the probability of individuals rating their SWB as “Happy” and “Very happy” decreases by 0.37% and 5.45% respectively. …”

Robustness test. by Tiantian Dong (6247917)

“…The findings indicate that consumption inequality has a significant negative impact on SWB. Specifically, for every unit increase in consumption inequality, the probability of individuals rating their SWB as “Happy” and “Very happy” decreases by 0.37% and 5.45% respectively. …”

Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different. P-values are obtained from Mann-Whitney test or T-test statistical analysis, depending of the normal distribution of data sets.... by Camille Quilgars (21156495)

“…The number of MNs recorded is indicated between brackets. ns: no significantly different. P-values are obtained from Mann-Whitney test or T-test statistical analysis, depending of the normal distribution of data sets. …”

<b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01).... by Atefeh Sadeghi (21253051)

“…Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01). …”

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022. by Myriam Aïche (22290591)

Subjects:

Association between platelet count and height loss by hypertension status. by Yuji Shimizu (174369)

Subjects:

Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

Subjects: